Role of the microenvironment in multiple myeloma bone disease

By Huston Alissa   Roodman G David  

Future Oncology, Vol. 2, Iss. 3, 2006-06 ,pp. : 371-378

Future Medicine

Access to resources Recommend Favorite

Imaging of Myeloma Bone Disease - Implications for Staging, Prognosis and Follow-up

By Dimopoulos Meletios A.   Moulopoulos Lia A.   Datseris Ioannis   Weber Donna   Delasalle Kay   Gika Dimitra   Alexanian Raymond  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 823-827

Informa Healthcare

Access to resources Recommend Favorite

Bone diesease in multiple myeloma

By Hjertner Øyvind   Standal Therese   Børset Magne   Sundan Anders   Waage Anders  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 431-441

Humana Press, Inc

Access to resources Recommend Favorite

Serum C terminal telopeptide maintains its correlation with bone disease in patients with myeloma even under treatment with bisphosphonates

By Pochintesta Lara   Mangiacavalli Silvia   Cocito Federica   Pompa Alessandra   Albertini Riccardo   Pascutto Cristiana   Ferretti Virginia Valeria   Cazzola Mario   Corso Alessandro  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1397-1398

Informa Healthcare

Access to resources Recommend Favorite

Effects of brucine on bone metabolism in multiple myeloma

By            

Molecular Medicine Reports, Vol. 6, Iss. 2, 2012-01 ,pp. : 367-370

Spandidos Publications

Access to resources Recommend Favorite